Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
EGL Genetic Diagnostics, |
RCV000261206 | SCV000333821 | pathogenic | not provided | 2015-08-30 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001058361 | SCV001222923 | pathogenic | Nemaline myopathy 2 | 2019-11-25 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln2129*) in the NEB gene. It is expected to result in an absent or disrupted protein product. This variant is present in population databases (rs80344795, ExAC 0.002%). This variant has been observed in individual(s) with nemaline myopathy (PMID: 25205138). ClinVar contains an entry for this variant (Variation ID: 282373). Loss-of-function variants in NEB are known to be pathogenic (PMID: 25205138). For these reasons, this variant has been classified as Pathogenic. |
Genomic Research Center, |
RCV001058361 | SCV001251740 | pathogenic | Nemaline myopathy 2 | 2020-05-03 | criteria provided, single submitter | clinical testing |